Site Activation: Keep Your Eyes on the Prize



Similar documents
How To Write A Binder Tab

The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial

Study Start-Up SS STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV)

No Page 1 of 5. Issue Date 4/21/2014

CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE]

The Study Site Master File and Essential Documents

Data Management & Case Report Form Development in Clinical Trials. Introduction to the Principles and Practice of Clinical Research.

Regulatory Binder Instructions 25 April 2016

CNE Disclosures. To change this title, go to Notes Master

Medical College of Georgia SOP NUMBER: 03 INVESTIGATIONAL DRUG HANDLING Version Number: 1.0, 1.1 Effective Date: 09/12/06, 08/02/10, 3/2/11

How Industry Can Partner with FDA in Defining a Risk- Based Monitoring Program

Vertex Investigator-Initiated Studies Program Overview

Quality Monitoring Checklist

Clinical Investigator Inspections and FDA-483 Observations

Good Documentation Practices

This unit will provide the structure needed to achieve successful supervision and oversight of the study. We will explain the importance of an

Reliance Agreement for Institutions Utilizing Stony Brook University s Institutional Review Board(s)

Essential Documents for the Conduct of a Clinical Trial. Debra Dykhuis Associate Director RSO

ROLE OF THE RESEARCH COORDINATOR Study Start-up Best Practices

Orientation Manual for Clinical Research Coordinators

Information Sheet Guidance for Sponsors, Clinical Investigators, and IRBs

DHHS/NIH/OD/OIR/OHSRP 1/2/2015

ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS

SOURCE DOCUMENTATION REQUIREMENTS

Essential Documents for Clinical Trial Research. Centre for Health Evaluation and Outcome Sciences Manager, Clinical Research Development Office

Clinical Investigator Training Course

Subject: No. Page PROTOCOL AND CASE REPORT FORM DEVELOPMENT AND REVIEW Standard Operating Procedure

Pre-Questions. Mastering Clinical Research July 29, 2015

DAIDS LMS Content List

INTERIM SITE MONITORING PROCEDURE

DAIDS Bethesda, MD USA POLICY. Requirements for Clinical Quality Management Plans

Objectives. Monitoring & Auditing of Clinical Trials. Overview. Pre-study Qualification Visit. Industry-sponsored Trials

Roles & Responsibilities of the Sponsor

TRIAL MASTER FILE- SPONSORED

Comprehensive Study Documents List (Biomedical Studies)

This policy applies to research administrators, investigators, research staff, Human Investigation Committee (HIC) members and HIC staff.

Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA Phone:

IMP management at site. Dmitry Semenyuta

Rashika Maharaj. Strategies for maintaining high standards for Good Clinical Laboratory Practices

Clinical Research Professional Certification & Preparing for the CCRP Exam

STANDARD OPERATING PROCEDURE FOR RESEARCH. Management of Essential Documents and Trial Folders

Monitoring & Auditing of Clinical Trials. Sponsored by Center for Cancer Research National Cancer Institute

DAIDS LMS Content List

Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health

2 Applicability: Effective Date: 1/15/2010 Revised: 8/13/2010, 9/10/10, 5/9/14

PREP Workshop #31: Preparing for Certification as a Clinical Research Coordinator

Principal Investigator Responsibilities for Education and Social/Behavioral Researchers

DAIDS Bethesda, MD USA. POLICY Requirements for Clinical Quality Management Plans

HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA CONSENT TO PARTICIPATE IN A RESEARCH STUDY AND RESEARCH SUBJECT HIPAA AUTHORIZATION

Guidance on Withdrawal of Subjects from Research: Data Retention and Other Related Issues

Establishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs)

Data Management in Clinical Trials

DAIDS Guidelines for Good Clinical Laboratory Practice Standards

If you are signing for a minor child, you refers to your child throughout the consent document.

The Importance of Following the PROTOCOL in Clinical Trials

Signature Requirements for the etmf

Essential Standard Operating Procedures Sample Templates Table of Contents

Investigator responsibilities for research conducted under the authority of the UTHSCSA Institutional Review Board (IRB)

The role, duties and responsibilities of clinical trials personnel Monitoring: rules and recommendations

Human Research Protection Program Good Clinical Practice Guidance for Investigators Investigator & Research Staff Responsibilities

12.0 Investigator Responsibilities

This policy applies to all clinical research conducted at Beaumont Health System.

IRB Submissions and Human Subjects Research Compliance. Georgia Health Sciences University

Objectives. The Paper Tells the Story

Data Management and Good Clinical Practice Patrick Murphy, Research Informatics, Family Health International

Use of Electronic Health Record Data in Clinical Investigations

QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH

Marie-Claire Rickard, GCP & Governance Manager Rachel Fay, GCP & Governance Manager Elizabeth Clough, R&D Operations Manager

ICH CRA Certification Guide March 2009

CHAPTER 7 QUALITY ASSESSMENT

Kandrea Collins, RN, BA, MA, Senior Clinical Team Manager Suzanne Olsen, RN, CCRC, Senior Clinical Research Associate

NRA FUNCTION IN CONTROLLING VACCINES IN CLINICAL TRIAL AND MARKETING AUTHORIZATION INDONESIA 2013 DVI MEETING 9 11 APRIL

CGIRB Connexus Tips. Version 1.1 July 2013 Copernicus Group IRB

Guidance for Industry Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions

Principal Investigator and Sub Investigator Responsibilities

Data Management Unit Research Institute for Health Sciences, Chiang Mai University

How to Run Clinical Trials in Private Practice

The Monitoring Visit. Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis

Guidance to Research Ethics Committees on Initial Facility Assessment

Children s Research Management System (CRMS) Version 3.0. Children s Hospital Colorado Research Institute Training Guide April 2015

CONTROLLED DOCUMENT- DO NOT COPY STANDARD OPERATING PROCEDURE. STH Investigator

Standard Operating Procedure: SOURCE DOCUMENTATION

UNIVERSITY OF CALIFORNIA, SAN DIEGO HUMAN RESEARCH PROTECTIONS PROGRAM HUMAN SUBJECT PROTECTION TRAINING

STANDARD OPERATING PROCEDURE NO. CM

PREP Course #27: Medical Device Clinical Trial Management

MINNEAPOLIS MEDICAL RESEARCH FOUNDATION CLINICAL RESEARCH STANDARD OPERATING PROCEDURES TABLE OF CONTENTS

GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group

John Keel, CPA State Auditor. An Audit Report on Inspections of Compounding Pharmacies at the Board of Pharmacy. August 2015 Report No.

STANDARD OPERATING POLICY AND PROCEDURE

CTSU Operational ET-CTN. April 21, 2013

CONDUCTING GLOBAL CLINICAL RESEARCH TRIALS:

Cellular Therapy Liaison Meeting 10 September 2009 BECS. M. Allene Carr-Greer, MT(ASCP)SBB Director, Regulatory Affairs AABB

Table of Contents. FACT Quality Handbook, Second Edition. Table of Contents

Transcription:

Site Activation: Keep Your Eyes on the Prize Theresa Gamble, Ph.D. Senior Clinical Research Manager HPTN CORE, FHI October 2004 Slide 1

The Prize Site-Specific Protocol Activation Notice See Example Document 1 Slide 2

Components of the Notice The following site has met all Protocol Registration and Study Activation requirements and is hereby approved to begin screening and enrollment in the study entitled: WITHOUT THE NOTICE, YOU CANNOT BEGIN THE STUDY!!! Slide 3

Current Federal Wide Assurance (FWA) For Each Relevant IRB/EC TIP 1) We check the OHRP website (http://www.hhs.gov/ohrp/) TIP 2) So should you Slide 4

Completion of US FDA 30-day Review Period TIP 1) This only applies to IND studies TIP 2) If you are an HPTN site, there is nothing for you to do (this is usually handled by DAIDS) Slide 5

Local Regulatory Authority Approval of the Study Protocol (other than IRB approval) TIP 1) Only the site knows if this is required TIP 2) Keep the HPTN CORE informed of the status and timeline TIP 3) The HPTN CORE or DAIDS can often help provide necessary documents or information TIP 4) Provide the HPTN CORE with documentation of approval in English Slide 6

Examples Local Regulatory Authority Approval of the Study Protocol Drug Controller General of India (DCGI) Health Ministry s Screening Committee (HMSC) Thai FDA Slide 7

Completion of Human Subjects Research Training for All Key Staff TIP 1) Key staff is defined by NIH as anyone who designs or conducts the study TIP 2) At a minimum, train all staff who interact with study participants TIP 3) Have a plan to train new staff Slide 8

Examples Completion of Human Subjects Research Training for All Key Staff www.hptn.org Annual HPTN Meeting At U.S. Institutions A copy of the attendance sheet or copies of the certificates are acceptable documentation Slide 9

Completion of Good Clinical Practice (GCP) Training by at Least One Study Staff Member with Responsibility for Oversight of Study Implementation TIP 1) Strongly recommend that as many staff as possible receive this training TIP 2) If only one or two staff can be trained, choose the Investigator of Record, the Investigator who signs the 1572, or the study coordinator TIP 3) Have a plan to train new staff Slide 10

Examples Completion of Good Clinical Practice (GCP) Training by at Least One Study Staff Member with Responsibility for Oversight of Study Implementation On Site PPD Training Annual HPTN Meeting Online Courses At U.S. Institutions or Companies A copy of the attendance sheet or copies of the certificates are acceptable documentation Slide 11

Protocol Registration Approval from the DAIDS RCC Protocol Registration Office based on: Approvals from all responsible IRBs/ECs IRB/EC-approved informed consent forms (local language and back-translation) Original Signed FDA Form 1572 or Investigator of Record Agreement CV of the Investigator of Record or 1572 Signee Slide 12

Slide 13 Protocol Registration Approval from the DAIDS RCC Protocol Registration Office TIP 1) Make sure your approval letters are in English and have the components required by the DAIDS Protocol Registration Manual TIP 2) Stay close to the ICF template, clearly label your consent forms, submit documentation of approval TIP 3) Check the 1572 or IoR for accuracy TIP 4) Have the IoR sign and date the CV

Examples IRB Approval Letter DAIDS-Required Elements Complete Protocol Title DAIDS Protocol Number DAIDS Protocol Version Number Date of IRB/EC Approval See Example Document 2 Slide 14

Examples IRB Approval Letter This is an excellent example of documenting that all consent forms have been approved. See Example Document 3 Slide 15

Examples IRB Approval Letter DAIDS-Required Elements IRB/EC Chairperson or Member Designee Signature IRB/EC Representative s Title Slide 16 See Example Document 4

Examples Protocol Registration Approval from DAIDS/RCC Protocol Registration Office Slide 17 See Example Document 5

DAIDS-Approved Pharmacy Establishment Plan (PEP) and Pharmacy SOP TIP 1) DAIDS PAB provides feedback and approval for these documents TIP 2) Provide HPTN CORE with documentation of approval TIP 3) Give yourself time there is usually some back and forth with DAIDS PAB Slide 18

All Applicable Import and Export Approvals for Study Products TIP 1) Only the site knows if these are required TIP 2) Keep the HPTN CORE informed of the status and timeline TIP 3) The HPTN CORE or DAIDS can often help provide necessary documents or information TIP 4) Provide the HPTN CORE with documentation of approval in English Slide 19

All Applicable Import and Export Approvals for Study Products TIP 5) Many parties are usually involved in this process - bureaucracy is the same all over - give yourself enough time!!! Slide 20

Study Staff Signature Sheet, Roster, and Delegation of Duties TIP 1) The easiest way to do this is a single log TIP 2) Your procedure should show when staff join and leave the project and if their duties change Slide 21

Examples Study Staff Signature Sheet, Roster, and Delegation of Duties NAME SIGNATURE INITIALS CREDENTIALS STUDY RESPONS- IBILITIES IoR DESIGNEE (Y/N) IF YES IoR INITIALS START DATE END DATE T. Gamble TRG Ph.D. B, C, G Y GD 01/01/04 01/30/04 M. McCauley MM MPH B, C, G Y GD 02/01/04 T. Gamble TRG Ph.D. D N 02/15/04 A, Investigator of Record B, Subinvestigator C, Verifies Eligibility D, Ships Specimens E, Study Coordinator F, Lab Technician G, Consents Participants H, Research Clinician I, Performs Study Assessments Slide 22

SCHARP Approval of Site Readiness for Data Management TIP 1) SCHARP Protocol Operations Coordinator (POC) guides preparedness activities and provides approval TIP 2) Stay in touch with your POC Slide 23

HPTN CL Approval of Local Laboratory Readiness TIP 1) HPTN Central Lab guides preparedness activities and provides approval TIP 2) The lab validation process takes time plan accordingly Slide 24

Required SOPs, Accrual and Retention Plans, and HIV Counseling Procedures TIP 1) Find out exactly what is required for your study TIP 2) Submit drafts early TIP 3) Agree on the process of review and approval TIP 4) Version 1.0 will change, don t agonize Slide 25

Examples SOP Review and Approval Process Set out expectations and timelines Designate point person for changes Use tracked changes appropriately Maintain version control SOPs can really help in the long run. Slide 26

PPD Study-Specific Initiation Visits TIP 1) Respond to the report in a timely fashion TIP 2) Proactively follow-up on issues Slide 27

Completion of Study-Specific Training and Resolution of Issues that are Identified during Training TIP 1) Use the training to walk-through your SOPs Slide 28 TIP 2) Clarify what issues are rate-limiting for site activation

Examples Resolution of issues that are identified during training REQUIRED FOR SITE ACTIVATION New IoR Agreement Site is missing CVs or financial disclosure forms Site has concerns about keeping drug within required temperature range The type of syphilis confirmatory test to be used for study was undetermined NOT REQUIRED FOR SITE ACTIVATION Approval of version 3.1 of ICFs when version 3.0 is available Finalize procedure to re-label medication that is nearing expiration Site will review ICFs and ICF process with CAB Site needs to hire an additional Medical Officer Slide 29

General Advice TIP 1) Determine a process of communication TIP 2) Track your progress TIP 3) Be organized TIP 4) Remember, we re all going to the same place, enjoy the ride Slide 30

Keep Your Eyes on the Prize Slide 31